Universal Health Realty Income Trust (UHT) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
7 Aug, 2026Executive summary
Net income for Q2 2026 was $5.9 million ($0.43 per diluted share), up from $4.5 million ($0.32 per diluted share) in Q2 2025, driven by a $724,000 gain on land sale, increased property income, and lower interest expense.
Adjusted net income for Q2 2026 was $5.2 million ($0.37 per diluted share), up $691,000 year-over-year.
Revenues for Q2 2026 rose to $25.0 million from $24.9 million in Q2 2025; six-month revenues were $49.5 million, up from $49.4 million year-over-year.
Funds from operations (FFO) for Q2 2026 increased to $12.5 million ($0.90/share) from $11.8 million ($0.85/share) in Q2 2025.
Financial highlights
Q2 2026 net income: $5.9 million; six-month net income: $10.9 million ($0.79 per diluted share).
Q2 2026 FFO: $12.5 million ($0.90/share); six-month FFO: $24.8 million ($1.79/share).
Q2 2026 revenues: $25.0 million; six-month revenues: $49.5 million.
Q2 2026 interest expense: $4.4 million, down from $4.7 million in Q2 2025.
Dividends paid in six months: $20.8 million ($1.495/share); Q2 2026 dividend: $0.75/share ($10.4 million).
Outlook and guidance
Management expects sufficient capital resources for the next twelve months, including funding for operations, investments, and dividends.
No shares issued under the $100 million shelf registration as of June 30, 2026; future issuances depend on market conditions.
Construction of Miller Medical Plaza (80,000 sq. ft. MOB) in Palm Beach Gardens, FL, commenced February 2026, expected completion December 2026, with a 10-year master lease for 75% of space at a cost of $34 million.
Latest events from Universal Health Realty Income Trust
- Trustee elections, executive pay, and auditor ratification all passed with no shareholder questions.UHT
AGM 202622 Jun 2026 - Trustees, executive pay, and auditor were approved by shareholders in a virtual meeting.UHT
AGM 202522 Jun 2026 - All proposals, including trustee elections and auditor ratification, were approved by shareholders.UHT
AGM 202421 Jun 2026 - Q2 and H1 2024 net income and FFO rose, with higher dividends and ongoing industry risks.UHT
Q2 202417 Jun 2026 - Net income, revenues, and FFO rose, with higher interest costs and expanded credit capacity.UHT
Q3 202417 Jun 2026 - Net income and FFO rose year-over-year, supported by property income and prudent capital actions.UHT
Q4 202417 Jun 2026 - Raised 2025 guidance after strong Q2 results and incremental Medicaid reimbursements.UHT
Q2 202517 Jun 2026 - Net income and FFO dipped, with new development underway and higher borrowing costs noted.UHT
Q4 202517 Jun 2026 - Mixed earnings and revenue trends, with stable liquidity but ongoing regulatory and litigation risks.UHT
Q1 202517 Jun 2026